アブレーションデバイスの市場規模、シェア、成長分析、技術別、用途別、エンドユーザー別、地域別 - 産業予測 2025～2032年

アブレーションデバイスの市場規模は2023年に94億米ドルで、2024年の104億2,000万米ドルから2032年には238億5,000万米ドルに成長し、予測期間中（2025-2032年）のCAGRは10.9%で推移する見通しです。

最近の手術法の進歩は、特に低侵襲手術の台頭など、ヘルスケア分野での大きな変革を反映しています。世界人口の高齢化と慢性疾患の複雑化に伴い、患者は術後のストレスを最小限に抑えた、侵襲の少ない治療法を求めるようになっています。気化、凍結、高周波などのアブレーション技術を含む低侵襲手術は、痛みの軽減、入院期間の短縮、回復時間の短縮といった利点をもたらします。腫瘍除去や組織治療のためのアブレーションへのシフトは、従来の手術に比べて侵襲性が低いことから、支持を集めています。がんや心血管系疾患のような慢性疾患が蔓延するにつれ、アブレーションデバイスの需要は急増すると予想され、患者ケアと外科技術革新における重要な動向を浮き彫りにしています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 規制情勢
• ケーススタディ
• 技術分析

アブレーションデバイス市場規模：技術別& CAGR（2025-2032）

• 市場概要
• 無線周波数デバイス
• レーザー/光アブレーション
• 超音波装置
• 凍結アブレーション装置
• その他の技術

アブレーションデバイス市場規模：用途別& CAGR（2025-2032）

• 市場概要
• 心臓病学
• 腫瘍学
• 眼科
• 婦人科
• 泌尿器科
• 美容整形
• その他の用途

アブレーションデバイス市場規模：エンドユーザー別& CAGR（2025-2032）

• 市場概要
• 病院
• 外来手術センター
• その他のエンドユーザー

アブレーションデバイス市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024年）

主要企業プロファイル

• Medtronic（Ireland）
• Boston Scientific Corporation（USA）
• Abbott Laboratories（USA）
• Johnson & Johnson（USA）
• AngioDynamics, Inc.（USA）
• AtriCure, Inc.（USA）
• Olympus Corporation（Japan）
• Smith & Nephew plc（UK）
• Stryker Corporation（USA）
• Avanos Medical, Inc.（USA）
• Hologic, Inc.（USA）
• Becton, Dickinson and Company（USA）
• Koninklijke Philips N.V.（Netherlands）
• Baylis Medical Company, Inc.（Canada）
• Elekta AB（Sweden）
• Haifu Medical Technology Co., Ltd.（China）
• Apyx Medical（formerly Bovie Medical）（USA）
• LeMaitre Vascular, Inc.（USA）
• Alcon Laboratories, Inc.（USA）
• Biotronik SE & Co. KG（Germany）

結論と提言

Ablation Devices Market size was valued at USD 9.4 billion in 2023 and is poised to grow from USD 10.42 billion in 2024 to USD 23.85 billion by 2032, growing at a CAGR of 10.9% during the forecast period (2025-2032).

Recent advancements in surgical methods reflect a significant transformation within the healthcare sector, especially with the rise of minimally invasive surgery. As the global population ages and the complexity of chronic diseases increases, patients increasingly seek less disruptive treatment options that minimize post-surgical stress. Minimally invasive procedures, including ablation techniques-such as vaporization, freezing, and radiofrequency-offer benefits of reduced pain, shorter hospital stays, and faster recovery times. This shift toward ablation for tumor removal and tissue treatment has gained traction due to its less intrusive nature compared to traditional surgeries. As chronic conditions like cancer and cardiovascular disease become more prevalent, the demand for ablation devices is expected to surge, highlighting a critical trend in patient care and surgical innovation.

Top-down and bottom-up approaches were used to estimate and validate the size of the Ablation Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Ablation Devices Market Segments Analysis

Global Ablation Devices Market is segmented by Technology, Application, End-user and region. Based on Technology, the market is segmented into Radiofrequency devices, Laser/light ablation, Ultrasound devices, Cryoablation devices and Other technologies. Based on Application, the market is segmented into Cardiology, Oncology, Ophthalmology, Gynecology, Urology, Cosmetic surgery and Other applications. Based on End-user, the market is segmented into Hospitals, Ambulatory surgical centers and Other end users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Ablation Devices Market

A significant factor driving the growth of the Ablation Devices market is the growing preference among patients for minimally invasive procedures instead of traditional open surgeries. In recent years, there has been a marked rise in the adoption and acceptance of minimally invasive therapies, largely due to their advantages, such as shorter hospital stays, quicker recovery times, and reduced discomfort when compared to conventional surgical methods. Additionally, the increasing prevalence of atrial fibrillation within the population is expected to lead to more cardiac ablation procedures. The ablation method for treating atrial fibrillation offers effective results with lower risks and enhanced convenience for patients. Consequently, the shift towards less invasive treatment options, combined with the increasing use of ablation devices, will significantly drive market growth in the coming years.

Restraints in the Ablation Devices Market

The Ablation Devices market faces substantial limitations due to the insufficient availability of effective conventional first-line medications for conditions like liver cancer, uterine fibroids, haemorrhagic stroke, and various haemorrhagic disorders. The dominant preference for therapies such as surgery, chemotherapy, and radiation is a major barrier, largely stemming from the high level of public awareness surrounding traditional cancer treatments. Additionally, the limited adoption of advanced treatment alternatives, especially in developing regions, coupled with oncologists' hesitance to move away from established treatment protocols, further exacerbates this issue. This resistance to embrace innovative solutions significantly hampers market growth.

Market Trends of the Ablation Devices Market

The Ablation Devices market is poised for significant growth in untapped regions such as Asia-Pacific, Africa, and Latin America, driven by advancements in ablation technologies and rising demand for minimally invasive therapies. Increasing disposable incomes in these areas further enhance market potential. Concurrently, the large undiagnosed patient population and rapid urbanization, which correlate with a rise in chronic illnesses, coupled with heightened awareness of conditions like prostate cancer, are catalysts for demand. Furthermore, augmented government funding for healthcare initiatives is anticipated to propel market expansion in these regions, making them increasingly attractive for industry stakeholders.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technology Analysis

Global Ablation Devices Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Radiofrequency devices
• Laser/light ablation
• Ultrasound devices
• Cryoablation devices
• Other technologies

Global Ablation Devices Market Size by Application & CAGR (2025-2032)

• Market Overview
• Cardiology
• Oncology
• Ophthalmology
• Gynecology
• Urology
• Cosmetic surgery
• Other applications

Global Ablation Devices Market Size by End-user & CAGR (2025-2032)

• Market Overview
• Hospitals
• Ambulatory surgical centers
• Other end users

Global Ablation Devices Market Size & CAGR (2025-2032)

• North America (Technology, Application, End-user)
  • US
  • Canada
• Europe (Technology, Application, End-user)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Technology, Application, End-user)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Technology, Application, End-user)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Technology, Application, End-user)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Medtronic (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AngioDynamics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AtriCure, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Olympus Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smith & Nephew plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Avanos Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baylis Medical Company, Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elekta AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Haifu Medical Technology Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Apyx Medical (formerly Bovie Medical) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LeMaitre Vascular, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alcon Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotronik SE & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations